HMGCR and cancer: While cholesterol plays crucial roles in malignant properties of cancer cells, whether blocking cholesterol biosynthesis by statins, HMGCR inhibitor, reduce the risk of cancer onset or mortality is controversial at present; the statin effects could be dependent on types of cancer (242–244).